Skip to content

The AMD Experts

Our Team

The MacuLogix team is committed to empowering primary eye care professionals with the technology and tools needed to turn their practice into an AMD Center of Excellence®.

Bill McPhee, the President and CEO of MacuLogix, shares his personal story of why he joined the company and adopted its vision of eliminating blindness caused by AMD.

By being able to test more patients, we’ll ultimately uncover more macular degeneration. That’s good for patients. And I think we all need to realize that what’s good for our patients winds up being good for our practices.

Jeffry D. Gerson, OD, FAAO Jeffry Gerson, OD, FAAO View all testimonials

Latest News & Upcoming Events

View More
Article: February 17, 2021 | Good Day PA

Talking All About Passionate Eye Care with Kirman Eye

In a special Good Day PA segment, an interviewer connected with Dr. Gary Kirman on the importance of optimal care when it comes to eye health, particularly with regard to AMD.

Our Blog: February 4, 2021

Two Birds, One Stone

Testing dark adaptation speed for every patient over 50 allows eye care professionals prioritize both patients and practice. By Tammy Tully, OD.

Article: December 30, 2020 | Review of Optometric Business

Treatment Plan & Technology Investment Generating More than $65,000 Annually

Victoria Dzurinko, OD, MBA, FAAO, discusses the opportunity available to improve both patient outcomes and practice bottom lines by integrating dark adaptation testing in the identification and management of AMD.

Put Our Expertise to Work

Testing with AdaptDx Pro

AdaptDx Pro identifies impaired dark adaptation—the earliest warning sign of AMD.

Implementation Expertise

Each AdaptDx Pro purchase is supported by our AMD Excellence Program® to help you achieve your patient care and practice revenue goals.